RDGL
VIVOS INC
stockOTC
advanced medical isotope corporation (amic) is a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications. amic's focus is on transitioning to full operations upon receipt of expected fda clearance for its patented brachytherapy cancer product, yttrium-90 radiogel™. amic intends to file fda premarket notifications for two related yttrium-90 brachytherapy products. brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area. annual sales of brachytherapy products exceed $1 billion, about half of which are in the united states. the company intends to outsource material aspects of manufacturing, distribution, sales and marketing for its products in the united states and to enter into licensing arrangements outside of the united states, though the company will evaluate its alternatives before finalizing its plans.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.04 | 2026-09-28 | +4.45% | -15.904 |
| 1M | 0.05 | 2026-09-04 | -9.13% | -1.212 |
| 3M | 0.09 | 2026-07-06 | -46.62% | -0.087 |
| 6M | 0.08 | 2026-04-06 | -46.05% | 0.707 |
| 1Y | 0.09 | 2025-10-03 | -49.05% | 0.213 |
| 2Y | 0.18 | 2024-10-04 | -73.83% | — |
| 5Y | 0.12 | 2021-10-04 | -61.02% | 0.034 |
VIVOS INC (OTC:RDGL) stock price today is $0.05, and today's volume is 663,531. RDGL is down 8.051% today. The 30 day average volume is 790,604. RDGL market cap is $19.12M with 417.56M shares outstanding.